• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cancer treatment and atrial fibrillation: use of pharmacovigilance databases to detect cardiotoxicity.

作者信息

Keramida Kalliopi, Filippatos Gerasimos, Farmakis Dimitrios

机构信息

Cardio-oncology Clinic, Heart Failure Unit, Department of Cardiology, National and Kapodistrian University of Athens Medical School, Athens University Hospital Attikon, Athens, Greece.

University of Cyprus Medical School, Nicosia, Cyprus.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):321-323. doi: 10.1093/ehjcvp/pvaa059.

DOI:10.1093/ehjcvp/pvaa059
PMID:32633808
Abstract
摘要

相似文献

1
Cancer treatment and atrial fibrillation: use of pharmacovigilance databases to detect cardiotoxicity.癌症治疗与心房颤动：利用药物警戒数据库检测心脏毒性
Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):321-323. doi: 10.1093/ehjcvp/pvaa059.
2
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study.阿比特龙致心力衰竭和房性快速性心律失常：一项药物警戒研究。
Arch Cardiovasc Dis. 2020 Jan;113(1):9-21. doi: 10.1016/j.acvd.2019.09.006. Epub 2019 Nov 2.
3
Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database.识别与心房颤动相关的抗癌药物：世卫组织药物警戒数据库分析。
Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):312-320. doi: 10.1093/ehjcvp/pvaa037.
4
Cholesterol embolisms as possible adverse drug reaction of direct oral anticoagulants.
Neth J Med. 2018 Apr;76(3):125-128.
5
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system.钠-葡萄糖协同转运蛋白 2（SGLT-2）抑制剂与食品和药物管理局不良事件报告系统中的心房颤动。
Cardiovasc Diabetol. 2021 Feb 11;20(1):39. doi: 10.1186/s12933-021-01243-4.
6
Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data.评估风险最小化措施的有效性：将概念框架应用于丹麦达比加群酯的真实世界数据
Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):607-614. doi: 10.1002/pds.4203. Epub 2017 Apr 11.
7
Incident atrial fibrillation hazard in hypertensive population: a risk function from and for clinical practice.高血压人群中心房颤动事件的危险：来自临床实践的风险函数。
Hypertension. 2015 Jun;65(6):1180-6. doi: 10.1161/HYPERTENSIONAHA.115.05198. Epub 2015 Apr 6.
8
Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban.非瓣膜性心房颤动患者主要出血情况的特征分析：一项针对27467例服用利伐沙班患者的药物警戒研究。
Clin Cardiol. 2015 Feb;38(2):63-8. doi: 10.1002/clc.22373. Epub 2015 Jan 14.
9
The incidence of atrial fibrillation with trastuzumab treatment: A systematic review and meta-analysis.曲妥珠单抗治疗相关的心房颤动发生率：一项系统评价和荟萃分析。
Cardiovasc Ther. 2018 Dec;36(6):e12475. doi: 10.1111/1755-5922.12475. Epub 2018 Nov 28.
10
Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication.接受免疫检查点抑制剂治疗的癌症患者中的应激性心肌病：一种新的不良心脏并发症。
Eur J Heart Fail. 2019 Jul;21(7):945-947. doi: 10.1002/ejhf.1497.

引用本文的文献

1
Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society.癌症患者及其幸存者的心律失常、传导障碍与心源性猝死：希腊心脏病学会心脏肿瘤学与电生理学工作组专家意见
Cardiooncology. 2025 Jul 28;11(1):71. doi: 10.1186/s40959-025-00363-0.
2
Cardiotoxicity in Elderly Breast Cancer Patients.老年乳腺癌患者的心脏毒性
Cancers (Basel). 2025 Jun 30;17(13):2198. doi: 10.3390/cancers17132198.
3
Crosslink between atrial fibrillation and cancer: a therapeutic conundrum.
心房颤动与癌症之间的联系：一个治疗难题。
Cardiooncology. 2024 Aug 7;10(1):48. doi: 10.1186/s40959-024-00243-z.
4
Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation.癌症合并心房颤动患者口服抗凝治疗的关系、当前问题、安全性及疗效
J Clin Med. 2023 Oct 16;12(20):6559. doi: 10.3390/jcm12206559.
5
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials.临床试验中作为单一疗法使用的抗癌药物暴露相关的房颤发生率
JACC CardioOncol. 2023 Mar 28;5(2):216-226. doi: 10.1016/j.jaccao.2022.11.019. eCollection 2023 Apr.
6
Dyspnea in Oncological Patients: a Brain Teaser.肿瘤患者的呼吸困难：一道难题。
Eur Cardiol. 2023 Feb 3;18:e03. doi: 10.15420/ecr.2021.62. eCollection 2023 Feb.
7
Anticoagulation for atrial fibrillation in active cancer.活动性癌症患者心房颤动的抗凝治疗
Oncol Lett. 2022 Apr;23(4):124. doi: 10.3892/ol.2022.13244. Epub 2022 Feb 17.